Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Media

December 2005

LCT awarded $100,000 grant by Cure Kids NZ more
December 22, 2005

LCT awarded $480,000 grant by NZTE more
December 21, 2005

Cell therapy supported through Bioethics recommendation more
December 14, 2005

Living Cell Technologies to meet with the US Food and Drug Administration (FDA) more
December 8, 2005

November 2005

LCT AGM told of strong progress in 2005 more
November 16, 2005

October 2005

Appendix 4C - Quarterly Cash Flow Report more
October 27, 2005

LCT files Pre-IND request letter with FDA for its NeurotrophinCell
product more
October 20, 2005

Leading US Neuroscientist appointed Chief Scientific Officer of LCT BioPharma more
October 12, 2005

LCT and MultiCell announce joint venture more
October 4, 2005

LCT awarded highly commended at NZ Hi-Tech Awards more
October 2, 2005

September 2005

LCT preliminary final report and full year accounts more
September 13, 2005

LCT named as finalist for the 2005 NZ Hi-Tech Awards more
September 1, 2005

August 2005

LCT raises $2.3 million in placement more more
August 9, 2005

LCT announces pre-clinical results for treating Huntington's disease more
August 2, 2005

July 2005

Quarterly Cash Flow Report Period Ended 30 June 200 more
July 29, 2005

April 2005

LCT reports nine-year survival of transplanted pig islet cells in a diabetic patient more
April 6, 2005

LCT successfully completes preclinical diabetes trial more
April 5, 2005

March 2005

LCT appoints Paris Brooke as General Manager more
March 10, 2005

LCT Acquires US$90m of Developed Cell Therapy Products more
March 03, 2005

 

February 2005

LCT achieves successful use of its DiabeCell product in preclinical diabetes trial more
February 24, 2005

Change of Company Secretary and registered address more
February 1, 2005

 

Archive 2007

Archive 2006

Archive 2004

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd